問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
張詩欣
下載
2024-10-04 - 2027-03-31
Condition/Disease
Test Drug
Participate Sites6Sites
Recruiting6Sites
2023-01-16 - 2028-10-31
Participate Sites7Sites
Recruiting7Sites
2024-09-01 - 2030-10-28
Participate Sites4Sites
Recruiting4Sites
2022-03-01 - 2029-12-31
2023-02-01 - 2029-04-30
Not yet recruiting3Sites
Recruiting3Sites
2022-11-01 - 2028-04-30
Participate Sites3Sites
2022-11-01 - 2025-04-14
Lung Diseases, Interstitial
BI 1015550
Participate Sites9Sites
Not yet recruiting8Sites
Recruiting1Sites
2023-05-01 - 2028-10-31
Participate Sites8Sites
Recruiting5Sites
xxxxxx
Efgartigimod PH20 SC
2018-11-01 - 2022-04-30
Systemic Lupus Erythematosus
Baricitinib
Terminated2Sites
Division of Rheumatology
全部
